IL-1 RECEPTOR ANTAGONIST RESTORES IL-18 NK CELL AXIS IN SYSTEMIC JIA

被引：0
|
作者：
De Jager, W. [1 ]
Vastert, S. J. [1 ]
Noordman, B. J. [1 ]
Prakken, B. J. [1 ]
Wulffraat, N. M. [1 ]
机构：
[1] Uunivers Med Ctr Utrecht, Utrecht, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.1738
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：71 / 72
页数：2
相关论文
共 50 条
  • [1] IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
    Sebastiaan J Vastert
    Wilco De Jager
    Bo Jan Noordman
    Berent J Prakken
    Nico M Wulffraat
    Journal of Translational Medicine, 10 (Suppl 3)
  • [2] Akinra restores the defective IL-18 NK cell axis in steroid naïve systemic onset JIA patients
    W de Jager
    SJ Vastert
    BJ Noordman
    D Holzinger
    W Kuis
    BJ Prakken
    NM Wulffraat
    Pediatric Rheumatology, 9 (Suppl 1)
  • [3] A tissue specific IL-1 receptor antagonist homolog front the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities
    Barton, JL
    Herbst, R
    Bosisio, D
    Higgins, L
    Nicklin, MJH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (11) : 3299 - 3308
  • [4] Analysis of serum interleukin(IL)-1α, IL-1β and IL-18 in patients with systemic sclerosis
    Lin, Emily
    Vincent, Fabien B.
    Sahhar, Joanne
    Ngian, Gene-Siew
    Kandane-Rathnayake, Rangi
    Mende, Rachel
    Morand, Eric F.
    Lang, Tali
    Harris, James
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2019, 8 (04)
  • [5] Regulation of IL-1 family cytokines IL-1α, IL-1 receptor antagonist, and IL-18 by 1,25-dihydroxyvitamin D3 in primary keratinocytes
    Kong, Juan
    Grando, Sergei A.
    Li, Yan Chun
    JOURNAL OF IMMUNOLOGY, 2006, 176 (06): : 3780 - 3787
  • [6] Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease
    Mi, Jiarui
    Liu, Zhengye
    Pei, Shengduo
    Wu, Xia
    Zhao, Nan
    Jiang, Lingjuan
    Zhang, Zhenjie
    Bai, Xiaoyin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 110
  • [7] IL-18 is involved in systemic JIA, but not in oligoarticular or polyarticular forms
    Nature Clinical Practice Rheumatology, 2007, 3 (11): : 594 - 594
  • [8] IL-18/IL-1/IL-17A axis: A novel therapeutic target for neonatal sepsis?
    Cross, Alan S.
    CYTOKINE, 2016, 86 : 1 - 3
  • [9] The IL-18/IFNγ axis in systemic JIA and MAS-new answers, more questions
    Schulert, Grant S.
    RHEUMATOLOGY, 2021, 60 (07) : 3045 - 3047
  • [10] Differences in signaling pathways by IL-1β and IL-18
    Lee, JK
    Kim, SH
    Lewis, EC
    Azam, T
    Reznikov, LL
    Dinarello, CA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (23) : 8815 - 8820
12345